1. Home
  2. AMTB vs FTRE Comparison

AMTB vs FTRE Comparison

Compare AMTB & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amerant Bancorp Inc.

AMTB

Amerant Bancorp Inc.

HOLD

Current Price

$22.70

Market Cap

864.2M

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.47

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTB
FTRE
Founded
1979
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
864.2M
829.3M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
AMTB
FTRE
Price
$22.70
$9.47
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$23.75
$15.39
AVG Volume (30 Days)
245.4K
1.2M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
1.58%
N/A
EPS Growth
386.36
N/A
EPS
1.26
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$8.12
N/A
Revenue Next Year
$7.78
$3.01
P/E Ratio
$18.07
N/A
Revenue Growth
N/A
1.00
52 Week Low
$15.62
$3.97
52 Week High
$23.55
$18.67

Technical Indicators

Market Signals
Indicator
AMTB
FTRE
Relative Strength Index (RSI) 65.56 42.51
Support Level $21.97 $8.85
Resistance Level $23.55 $11.22
Average True Range (ATR) 0.59 0.62
MACD 0.20 0.16
Stochastic Oscillator 98.93 53.29

Price Performance

Historical Comparison
AMTB
FTRE

About AMTB Amerant Bancorp Inc.

Amerant Bancorp Inc is a bank holding company. Through its bank, it provides individuals and businesses deposit, credit, investment, wealth management, and fiduciary services, both in the United States and to select international customers. The bank also provides banking services through traditional channels, such as banking centers and ATMs, as well as via secure websites, mobile devices and telephones.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: